The role of regulatory sequences such as promoters, enhancers and untranslated regions (UTRs) on gene expression through the direct control of transcription rates or mRNA stability is well established. While these regulatory elements are usually sufficient to obtain satisfactory gene expression levels in vitro, effective gene expression in transgenic animals was found to be greatly enhanced by the presence of introns. 1 The in vivo expression levels obtained with cDNA, genomic DNA (gDNA), cDNA/gDNA hybrid transgenes or cDNA containing a heterologous intron showed that genomic gene loci were a favourable substrate for transgene expression.
Somatic gene therapy could, in principle, also benefit from the use of recombinant genomic loci encoding therapeutic gene products. Limited capacity to accommodate foreign DNA, however, can restrict the use of large gDNA fragments in gene delivery vector systems. Therefore, coding sequences are usually included without introns, as cDNA. To make use of the beneficial effect of mRNA splicing, while maintaining the integrity of the cDNA coding sequence, an intron has often been included at one end of the transcription unit. 2 Only rarely have autologous introns been re-inserted into cDNA reading frames. 3 Also, gDNA/cDNA hybrid genes have also leads to a 30-fold enhancement of mRNA production for both green fluorescent protein and the bacteriophage P1-derived Cre recombinase. The levels of green fluorescence were increased five-fold in cell lines and sustained long-term expression at increased levels was observed in rat brain after transduction with a herpes simplex virus-based vector.
The data presented identify a means by which the expression of recombinant genes can be enhanced considerably, in addition to and independently from the surrounding regulatory sequences. The method should help obtain sustained and effective expression of recombinant proteins in vivo. Gene Therapy (2001) 8, 649-653.
been used to improve expression of the therapeutic protein. 4 Here we report that the beneficial effect of introns on gene expression can be transferred to open reading frames by direct insertion of short heterologous introns. This creates a gene structure reminiscent of typical mammalian genes with similarly spaced splice consensus sequences to provide a near-natural substrate for gene expression. We aimed to improve the expression of the naturally intronless green fluorescent protein (GFP), and the bacteriophage P1-derived Cre recombinase, which are widely used as a reporter gene, 5, 6 or to induce site-specific DNA recombination in vitro and in vivo. [7] [8] [9] Minigenes with an artificial exon-intron structure (iDNA) encoding GFP or Cre were generated by insertion of two introns derived from loci encoding the mouse immunoglobulin (Ig) heavy chains into the respective open-reading frames. Introns from the loci encoding immunoglobulin (Ig) heavy chain constant regions were chosen, because they are short and compatible with high levels of protein expression. Furthermore, there is neither evidence for alternative splicing of these introns nor for the presence of regulatory sequences such as transcriptional enhancers or repressors, which could interfere with gene expression in 'non-B lymphocytes'.
The first intron of the mouse Ig C gene and the third intron of mouse Ig C⑀ were amplified by PCR and ligated into SmaI and PvuII restriction sites that had been introduced for this purpose by PCR directed 'silent' mutagenesis into the eGFP coding sequence (Figure 1 ). In 
CCAGTCGACCCCCTTTCCTGCTCTTGC) and bgloba2 (GTCAGATCTCAGATTTTCAAATGTCTATC). These cloning strategies produced pairs of Cre and GFP coding sequences differing only by the presence or absence of introns. The coding sequences were cloned into an expression vector (pEGFP-N1, Clonetech) replacing either the eGFP gene alone (for iGFP/eGFP vectors) or eGFP and the resident SV40 polyadenylation signal (iCre2/Cre(x) vectors). The resulting plasmids were used in transfection studies.
the case of Cre, the introns were introduced into EcoRV and PvuII sites of a modified Cre coding sequence. GC pairs present in this bacterial gene had previously been removed by silent mutagenesis ((Cre(x); our unpublished data) to prevent inhibitory DNA methylation in mammalian cells.
We determined the effect of the introns on gene expression by stable transfection of CHO cells with expression constructs under control of the CMV promoter. Pools of approximately 100 G418 resistant clones were analysed to minimise the possible influence of integration site-specific effects. While the introns were spliced correctly to produce functional GFP mRNA (Figure 2a) , cryptic splice donor site in position 447 (GAG/GT) was activated in the Cre coding sequence that led to deletion of 120 nucleotides of the first exon (see Figure 1b , data not shown). 'Weakening' of this splice consensus sequence by mutagenesis of two bases (Figure 1b) led to the correct splice product (Figure 2b ). DNA sequencing of the rtPCR products (data not shown) confirmed functional splicing and reconstitution of the open reading frames for iGFP and iCRE2. Quantification of GFP and Cre mRNA levels by RNA slot blot analysis revealed a substantial effect of the introns on gene expression: the iDNA constructs produced 30-fold higher levels of steady-state mRNA compared to the intronless counterparts ( Figure 2) . Expression of functional protein was confirmed by the ability of the Cre recombinase to delete a loxP flanked premature transcriptional stop sequence leading to activation of a GFP reporter construct (data not shown), and the emission of green fluorescence by cells transfected with iGFP as detailed below.
The effect of the introns on GFP expression was analysed further in vitro and in vivo at the protein level. Flowcytometric analysis of randomly selected CHO clones transfected with the GFP expression plasmids ( Figure 3) showed a higher proportion of fluorescent cells (60 ± 7.4%, iGFP versus 41 ± 5.9% eGFP), and more homogeneous fluorescence as indicated by the respective coefficient of variation (CV) values (148 ± 8.8 iGFP, 182 ± 11.9 eGFP). Remarkably, the clones transfected with the iGFP construct showed a five-fold higher level of mean fluorescence compared with eGFP ( Figure 3 ). The presence of introns in the coding sequence of GFP thus improves both levels and homogeneity of gene expression. To determine whether the artificial exon-intron structure would also lead to enhanced gene expression in vivo, rat brain was transduced with a herpes simplex virus (HSV) based vector 10 encoding the eGFP or the iGFP construct. Levels of GFP expression 3 days after transduction were notably higher in the case of iGFP with increased fluorescence (data not shown). The intron-mediated enhancement, however, became most apparent 4 weeks after transduction (Figure 3) . Sections of brain tissue transduced with iGFP expression vectors showed larger areas with more intense fluorescence and staining deep into the axons. Taken together, the data show that artificial exon-intron structures created by direct insertion of short heterologous introns into coding sequences can boost the expression of recombinant genes in vitro and in vivo.
The insertion of introns directly into coding sequences has some distinct advantages over the positioning of an intron in the UTR, the use of genomic/cDNA hybrid genes, or incorporation of UTRs. 11 First, introns can act co-operatively in enhancing the levels of mRNA pro- duced 12 -an effect that would require the presence of at least two introns. Second, genomic/cDNA hybrid genes usually contain authentic introns that are considerably larger than the minimal sequences required for efficient splicing and they can therefore represent an unnecessary load for gene delivery systems with limited capacity for foreign DNA. Recently, a UTR from the wood-chuck hepatitis virus has been shown to enhance recombinant gene expression. 11 While such an approach may well represent an important step forward in achieving therapeutic levels of protein expression in vivo, it is associated with the expression of viral genetic information in the mRNA. Introns, however, which can be of autologous, heterologous or synthetic origin, are removed completely from the mature mRNA.
GFP coding sequence without introns is indicated by a product of 759 bp (including 26 nucleotides from the UTRs), while the presence of the two introns leads to a product of 949 bp. Digestion with SmaI (S) or PvuII (P) leads to generation of 563/196 and 401/357 bp product pairs, respectively, indicating the reconstitution of the ORF. Cre coding sequence without introns is indicated by a product of 904 bp, while the presence of the two introns leads to a product of 1094 bp. Digestion with EcoRV (E) or Pvu II (P) leads to generation of 471/433 and 649/255 bp product pairs, respectively, indicating precise removal of the introns and the reconstitution of the ORF. No PCR products were generated in negative control samples treated in the absence of reverse transcriptase to exclude amplification from contaminating chromosomal DNA. (c, d) Levels of GFP and
The positive effect of introns on gene expression may be related to their reported influence on the local chromatin structure, 13 through the possible effect of splice junction sequences on nucleosome arrangement.
14 Also, the formation of the splicesosome may help stabilise RNA and support the efficient production of the mature transcript. Through mechanisms, which are only beginning to be understood, eukaryotic cells can recognise foreign DNA and inhibit its expression, a phenomenon described as gene silencing. It has become apparent for example in Gene Therapy the de novo methylation and silencing of retroviral genes, transgene silencing in mice or RNA interferencephenomena that are likely to also affect the expression of therapeutic genes in humans (reviewed in Ref. 15 ).
Currently used therapeutic recombinant genes are usually uninterrupted coding sequences presented in the from of cDNA or cDNA/gDNA hybrids with few, if any introns. Recognition of these sequences as 'alien' and subsequent epigenetic silencing of the locus may well contribute to the difficulties in achieving sustained expression of recombinant genes in vivo. These considerations and the data presented here would support the generation of near-natural, alternating exon-intron structures to obtain satisfactory expression of recombinant DNA in vivo. This can be achieved by direct insertion of small introns into coding regions. Studies with Ig genes showed that the positive effect of introns on gene expression can depend on the promoter used. 16 Remarkably, CMV promoter-driven expression was not increased by introns in this B cell system. Given that Ig introns do have a pronounced effect on CMV promoter driven expression of Cre and GFP in CHO cells as shown here, cell type-specific factors may play a role in the possible interaction between promoter region and coding sequences. Therefore, it would seem important to test promoter/intron combinations in the appropriate cellular systems to maximise recombinant gene expression in the target tissue. The method described here should be generally applicable to improve recombinant gene expression independently, or in combination with promoter choice and other methods such as the use of mRNA stabilising sequences.
Figure 3 Enhanced GFP protein expression upon intron insertion. (a) GFP expression indicated by fluorescence of CHO clones transfected with eGFP (dotted line) or iGFP (bold line) and untransfected control cells (thin line). (b) Fluorescence of clones transfected with iGFP (closed symbols) or eGFP (open symbols). Untransfected CHO cells showed a background fluorescence of 3.2 relative fluorescent units (see panel a). The mean values are indicated by horizontal bars. (c, d) GFP expression in rat brain 4 weeks after transduction with herpes simplex based vector expressing either eGFP (c) or iGFP (d). The relative increase in background fluorescence in the eGFP sample (c) is due to the longer exposure time (1 s) compared with iGFP (0.5 s) (d), to document the area of weak GFP fluorescence in (c
11 A near-natural gene organisation of alternating exons and introns should help achieve the sustained levels of gene expression required for effective protein function and therapeutic efficiency in vivo.
